nodes	percent_of_prediction	percent_of_DWPC	metapath
Morphine—CYP2C8—Spironolactone—dilated cardiomyopathy	0.19	0.409	CbGbCtD
Morphine—ABCB1—Lisinopril—dilated cardiomyopathy	0.146	0.314	CbGbCtD
Morphine—ABCB1—Spironolactone—dilated cardiomyopathy	0.128	0.277	CbGbCtD
Morphine—UGT2B4—pericardium—dilated cardiomyopathy	0.0526	0.568	CbGeAlD
Morphine—Bladder spasm—Furosemide—dilated cardiomyopathy	0.0224	0.0623	CcSEcCtD
Morphine—UGT2B4—cardiac ventricle—dilated cardiomyopathy	0.0124	0.134	CbGeAlD
Morphine—UGT2B4—myocardium—dilated cardiomyopathy	0.0117	0.126	CbGeAlD
Morphine—Menstruation irregular—Spironolactone—dilated cardiomyopathy	0.00934	0.0259	CcSEcCtD
Morphine—UGT2B4—heart—dilated cardiomyopathy	0.00813	0.0878	CbGeAlD
Morphine—Hypotensive—Furosemide—dilated cardiomyopathy	0.00771	0.0214	CcSEcCtD
Morphine—UGT2B4—cardiac atrium—dilated cardiomyopathy	0.00696	0.0751	CbGeAlD
Morphine—Amenorrhoea—Spironolactone—dilated cardiomyopathy	0.00588	0.0163	CcSEcCtD
Morphine—Ulcer—Spironolactone—dilated cardiomyopathy	0.00546	0.0152	CcSEcCtD
Morphine—Gynaecomastia—Spironolactone—dilated cardiomyopathy	0.00462	0.0128	CcSEcCtD
Morphine—Appetite absent—Lisinopril—dilated cardiomyopathy	0.00424	0.0118	CcSEcCtD
Morphine—Apathy—Furosemide—dilated cardiomyopathy	0.00394	0.0109	CcSEcCtD
Morphine—Blister—Furosemide—dilated cardiomyopathy	0.0039	0.0108	CcSEcCtD
Morphine—Flat affect—Furosemide—dilated cardiomyopathy	0.0039	0.0108	CcSEcCtD
Morphine—Lethargy—Spironolactone—dilated cardiomyopathy	0.00383	0.0106	CcSEcCtD
Morphine—Sleep disturbance—Lisinopril—dilated cardiomyopathy	0.00376	0.0105	CcSEcCtD
Morphine—Inappropriate antidiuretic hormone secretion—Lisinopril—dilated cardiomyopathy	0.00363	0.0101	CcSEcCtD
Morphine—Ataxia—Spironolactone—dilated cardiomyopathy	0.00353	0.0098	CcSEcCtD
Morphine—Injection site pain—Furosemide—dilated cardiomyopathy	0.00344	0.00956	CcSEcCtD
Morphine—Cramp muscle—Spironolactone—dilated cardiomyopathy	0.00338	0.00938	CcSEcCtD
Morphine—Eosinophilia—Spironolactone—dilated cardiomyopathy	0.00321	0.00892	CcSEcCtD
Morphine—Drug interaction—Furosemide—dilated cardiomyopathy	0.00303	0.00842	CcSEcCtD
Morphine—Erectile dysfunction—Spironolactone—dilated cardiomyopathy	0.00299	0.00829	CcSEcCtD
Morphine—Drowsiness—Spironolactone—dilated cardiomyopathy	0.00289	0.00803	CcSEcCtD
Morphine—Renal failure—Spironolactone—dilated cardiomyopathy	0.00284	0.00789	CcSEcCtD
Morphine—Rhinorrhoea—Lisinopril—dilated cardiomyopathy	0.0026	0.00723	CcSEcCtD
Morphine—Bladder pain—Furosemide—dilated cardiomyopathy	0.00254	0.00706	CcSEcCtD
Morphine—Lightheadedness—Furosemide—dilated cardiomyopathy	0.00252	0.00699	CcSEcCtD
Morphine—Mental disability—Furosemide—dilated cardiomyopathy	0.00244	0.00678	CcSEcCtD
Morphine—Accidental injury—Lisinopril—dilated cardiomyopathy	0.00238	0.00662	CcSEcCtD
Morphine—Chest discomfort—Lisinopril—dilated cardiomyopathy	0.00238	0.00662	CcSEcCtD
Morphine—Polyuria—Furosemide—dilated cardiomyopathy	0.00232	0.00646	CcSEcCtD
Morphine—Swelling—Furosemide—dilated cardiomyopathy	0.00231	0.00643	CcSEcCtD
Morphine—Oliguria—Lisinopril—dilated cardiomyopathy	0.00229	0.00636	CcSEcCtD
Morphine—Drug interaction—Lisinopril—dilated cardiomyopathy	0.00227	0.00632	CcSEcCtD
Morphine—Haemolytic anaemia—Furosemide—dilated cardiomyopathy	0.00226	0.00628	CcSEcCtD
Morphine—Muscle spasms—Spironolactone—dilated cardiomyopathy	0.00217	0.00603	CcSEcCtD
Morphine—Thirst—Furosemide—dilated cardiomyopathy	0.00214	0.00596	CcSEcCtD
Morphine—Dermatitis bullous—Furosemide—dilated cardiomyopathy	0.00214	0.00593	CcSEcCtD
Morphine—Pulmonary embolism—Lisinopril—dilated cardiomyopathy	0.00211	0.00586	CcSEcCtD
Morphine—Ventricular tachycardia—Lisinopril—dilated cardiomyopathy	0.00211	0.00586	CcSEcCtD
Morphine—Anaphylactoid reaction—Furosemide—dilated cardiomyopathy	0.00211	0.00586	CcSEcCtD
Morphine—Ill-defined disorder—Spironolactone—dilated cardiomyopathy	0.0021	0.00582	CcSEcCtD
Morphine—Lethargy—Furosemide—dilated cardiomyopathy	0.00208	0.00578	CcSEcCtD
Morphine—Hyponatraemia—Furosemide—dilated cardiomyopathy	0.00205	0.00569	CcSEcCtD
Morphine—Wheezing—Lisinopril—dilated cardiomyopathy	0.00205	0.00569	CcSEcCtD
Morphine—Malaise—Spironolactone—dilated cardiomyopathy	0.00204	0.00566	CcSEcCtD
Morphine—Leukopenia—Spironolactone—dilated cardiomyopathy	0.00202	0.00562	CcSEcCtD
Morphine—Urinary retention—Furosemide—dilated cardiomyopathy	0.00194	0.00539	CcSEcCtD
Morphine—Bladder pain—Lisinopril—dilated cardiomyopathy	0.00191	0.0053	CcSEcCtD
Morphine—Discomfort—Spironolactone—dilated cardiomyopathy	0.0019	0.00528	CcSEcCtD
Morphine—Dehydration—Furosemide—dilated cardiomyopathy	0.0019	0.00527	CcSEcCtD
Morphine—Lightheadedness—Lisinopril—dilated cardiomyopathy	0.00189	0.00524	CcSEcCtD
Morphine—Pulmonary oedema—Lisinopril—dilated cardiomyopathy	0.00188	0.00522	CcSEcCtD
Morphine—Orthostatic hypotension—Furosemide—dilated cardiomyopathy	0.00186	0.00518	CcSEcCtD
Morphine—Confusional state—Spironolactone—dilated cardiomyopathy	0.00186	0.00516	CcSEcCtD
Morphine—Hypokalaemia—Furosemide—dilated cardiomyopathy	0.00186	0.00516	CcSEcCtD
Morphine—Hypertonia—Lisinopril—dilated cardiomyopathy	0.00185	0.00514	CcSEcCtD
Morphine—Anaphylactic shock—Spironolactone—dilated cardiomyopathy	0.00184	0.00512	CcSEcCtD
Morphine—Cramp muscle—Furosemide—dilated cardiomyopathy	0.00184	0.0051	CcSEcCtD
Morphine—Thrombocytopenia—Spironolactone—dilated cardiomyopathy	0.00181	0.00501	CcSEcCtD
Morphine—Abdominal distension—Furosemide—dilated cardiomyopathy	0.00178	0.00493	CcSEcCtD
Morphine—Sleep disorder—Lisinopril—dilated cardiomyopathy	0.00177	0.00491	CcSEcCtD
Morphine—Eosinophilia—Furosemide—dilated cardiomyopathy	0.00175	0.00485	CcSEcCtD
Morphine—Gastroenteritis—Lisinopril—dilated cardiomyopathy	0.00173	0.0048	CcSEcCtD
Morphine—Haemolytic anaemia—Lisinopril—dilated cardiomyopathy	0.0017	0.00471	CcSEcCtD
Morphine—Injury—Lisinopril—dilated cardiomyopathy	0.00167	0.00463	CcSEcCtD
Morphine—Libido decreased—Lisinopril—dilated cardiomyopathy	0.00165	0.00459	CcSEcCtD
Morphine—Somnolence—Spironolactone—dilated cardiomyopathy	0.00164	0.00455	CcSEcCtD
Morphine—Atrial fibrillation—Lisinopril—dilated cardiomyopathy	0.00162	0.00449	CcSEcCtD
Morphine—Renal impairment—Lisinopril—dilated cardiomyopathy	0.00161	0.00447	CcSEcCtD
Morphine—Gastrointestinal disorder—Spironolactone—dilated cardiomyopathy	0.00159	0.00442	CcSEcCtD
Morphine—Hyperglycaemia—Furosemide—dilated cardiomyopathy	0.00159	0.00442	CcSEcCtD
Morphine—Anaphylactoid reaction—Lisinopril—dilated cardiomyopathy	0.00158	0.00439	CcSEcCtD
Morphine—Drowsiness—Furosemide—dilated cardiomyopathy	0.00157	0.00437	CcSEcCtD
Morphine—Renal failure—Furosemide—dilated cardiomyopathy	0.00155	0.00429	CcSEcCtD
Morphine—Hyponatraemia—Lisinopril—dilated cardiomyopathy	0.00154	0.00427	CcSEcCtD
Morphine—Osteoarthritis—Lisinopril—dilated cardiomyopathy	0.00153	0.00425	CcSEcCtD
Morphine—Diplopia—Lisinopril—dilated cardiomyopathy	0.00153	0.00425	CcSEcCtD
Morphine—Feeling abnormal—Spironolactone—dilated cardiomyopathy	0.00152	0.00422	CcSEcCtD
Morphine—Disturbance in sexual arousal—Lisinopril—dilated cardiomyopathy	0.00152	0.00422	CcSEcCtD
Morphine—Sweating—Furosemide—dilated cardiomyopathy	0.00151	0.00419	CcSEcCtD
Morphine—Hepatobiliary disease—Furosemide—dilated cardiomyopathy	0.00149	0.00413	CcSEcCtD
Morphine—Urticaria—Spironolactone—dilated cardiomyopathy	0.00146	0.00407	CcSEcCtD
Morphine—Body temperature increased—Spironolactone—dilated cardiomyopathy	0.00146	0.00405	CcSEcCtD
Morphine—Cardiac arrest—Lisinopril—dilated cardiomyopathy	0.00146	0.00404	CcSEcCtD
Morphine—Ataxia—Lisinopril—dilated cardiomyopathy	0.00144	0.004	CcSEcCtD
Morphine—Dehydration—Lisinopril—dilated cardiomyopathy	0.00142	0.00396	CcSEcCtD
Morphine—Orthostatic hypotension—Lisinopril—dilated cardiomyopathy	0.0014	0.00388	CcSEcCtD
Morphine—Urinary tract disorder—Furosemide—dilated cardiomyopathy	0.00139	0.00387	CcSEcCtD
Morphine—Urethral disorder—Furosemide—dilated cardiomyopathy	0.00138	0.00384	CcSEcCtD
Morphine—Breast disorder—Lisinopril—dilated cardiomyopathy	0.00138	0.00384	CcSEcCtD
Morphine—Cramp muscle—Lisinopril—dilated cardiomyopathy	0.00138	0.00383	CcSEcCtD
Morphine—Nasopharyngitis—Lisinopril—dilated cardiomyopathy	0.00137	0.0038	CcSEcCtD
Morphine—Visual impairment—Furosemide—dilated cardiomyopathy	0.00136	0.00378	CcSEcCtD
Morphine—Hypersensitivity—Spironolactone—dilated cardiomyopathy	0.00136	0.00377	CcSEcCtD
Morphine—Influenza—Lisinopril—dilated cardiomyopathy	0.00132	0.00368	CcSEcCtD
Morphine—Eye disorder—Furosemide—dilated cardiomyopathy	0.00132	0.00366	CcSEcCtD
Morphine—Eosinophilia—Lisinopril—dilated cardiomyopathy	0.00131	0.00364	CcSEcCtD
Morphine—Pruritus—Spironolactone—dilated cardiomyopathy	0.0013	0.00362	CcSEcCtD
Morphine—Bronchospasm—Lisinopril—dilated cardiomyopathy	0.0013	0.00362	CcSEcCtD
Morphine—Sweating increased—Lisinopril—dilated cardiomyopathy	0.00129	0.00358	CcSEcCtD
Morphine—Angiopathy—Furosemide—dilated cardiomyopathy	0.00128	0.00356	CcSEcCtD
Morphine—Diarrhoea—Spironolactone—dilated cardiomyopathy	0.00126	0.0035	CcSEcCtD
Morphine—Dysuria—Lisinopril—dilated cardiomyopathy	0.00124	0.00344	CcSEcCtD
Morphine—Malnutrition—Furosemide—dilated cardiomyopathy	0.00123	0.00341	CcSEcCtD
Morphine—Erythema—Furosemide—dilated cardiomyopathy	0.00123	0.00341	CcSEcCtD
Morphine—Dizziness—Spironolactone—dilated cardiomyopathy	0.00122	0.00339	CcSEcCtD
Morphine—Erectile dysfunction—Lisinopril—dilated cardiomyopathy	0.00122	0.00339	CcSEcCtD
Morphine—Flatulence—Furosemide—dilated cardiomyopathy	0.00121	0.00336	CcSEcCtD
Morphine—Dysgeusia—Furosemide—dilated cardiomyopathy	0.0012	0.00334	CcSEcCtD
Morphine—Weight decreased—Lisinopril—dilated cardiomyopathy	0.0012	0.00333	CcSEcCtD
Morphine—Hyperglycaemia—Lisinopril—dilated cardiomyopathy	0.00119	0.00332	CcSEcCtD
Morphine—Muscle spasms—Furosemide—dilated cardiomyopathy	0.00118	0.00328	CcSEcCtD
Morphine—Vomiting—Spironolactone—dilated cardiomyopathy	0.00117	0.00326	CcSEcCtD
Morphine—Rash—Spironolactone—dilated cardiomyopathy	0.00116	0.00323	CcSEcCtD
Morphine—Dermatitis—Spironolactone—dilated cardiomyopathy	0.00116	0.00323	CcSEcCtD
Morphine—Renal failure—Lisinopril—dilated cardiomyopathy	0.00116	0.00322	CcSEcCtD
Morphine—Vision blurred—Furosemide—dilated cardiomyopathy	0.00116	0.00322	CcSEcCtD
Morphine—Headache—Spironolactone—dilated cardiomyopathy	0.00116	0.00321	CcSEcCtD
Morphine—Urinary tract infection—Lisinopril—dilated cardiomyopathy	0.00115	0.00319	CcSEcCtD
Morphine—Anaemia—Furosemide—dilated cardiomyopathy	0.00114	0.00316	CcSEcCtD
Morphine—Sweating—Lisinopril—dilated cardiomyopathy	0.00113	0.00314	CcSEcCtD
Morphine—Agitation—Furosemide—dilated cardiomyopathy	0.00113	0.00314	CcSEcCtD
Morphine—Hepatobiliary disease—Lisinopril—dilated cardiomyopathy	0.00112	0.0031	CcSEcCtD
Morphine—Vertigo—Furosemide—dilated cardiomyopathy	0.0011	0.00307	CcSEcCtD
Morphine—Leukopenia—Furosemide—dilated cardiomyopathy	0.0011	0.00306	CcSEcCtD
Morphine—Nausea—Spironolactone—dilated cardiomyopathy	0.0011	0.00304	CcSEcCtD
Morphine—Bradycardia—Lisinopril—dilated cardiomyopathy	0.00108	0.003	CcSEcCtD
Morphine—Rhinitis—Lisinopril—dilated cardiomyopathy	0.00106	0.00295	CcSEcCtD
Morphine—Hepatitis—Lisinopril—dilated cardiomyopathy	0.00106	0.00294	CcSEcCtD
Morphine—Hallucination—Lisinopril—dilated cardiomyopathy	0.00105	0.00293	CcSEcCtD
Morphine—Urinary tract disorder—Lisinopril—dilated cardiomyopathy	0.00105	0.00291	CcSEcCtD
Morphine—Oedema peripheral—Lisinopril—dilated cardiomyopathy	0.00104	0.0029	CcSEcCtD
Morphine—Unspecified disorder of skin and subcutaneous tissue—Furosemide—dilated cardiomyopathy	0.00104	0.00289	CcSEcCtD
Morphine—Urethral disorder—Lisinopril—dilated cardiomyopathy	0.00104	0.00288	CcSEcCtD
Morphine—Dry mouth—Furosemide—dilated cardiomyopathy	0.00102	0.00284	CcSEcCtD
Morphine—Confusional state—Furosemide—dilated cardiomyopathy	0.00101	0.00281	CcSEcCtD
Morphine—Anaphylactic shock—Furosemide—dilated cardiomyopathy	0.001	0.00279	CcSEcCtD
Morphine—Shock—Furosemide—dilated cardiomyopathy	0.000987	0.00274	CcSEcCtD
Morphine—Nervous system disorder—Furosemide—dilated cardiomyopathy	0.000984	0.00273	CcSEcCtD
Morphine—Flushing—Lisinopril—dilated cardiomyopathy	0.000983	0.00273	CcSEcCtD
Morphine—Thrombocytopenia—Furosemide—dilated cardiomyopathy	0.000982	0.00273	CcSEcCtD
Morphine—Skin disorder—Furosemide—dilated cardiomyopathy	0.000974	0.00271	CcSEcCtD
Morphine—Hyperhidrosis—Furosemide—dilated cardiomyopathy	0.00097	0.00269	CcSEcCtD
Morphine—Angiopathy—Lisinopril—dilated cardiomyopathy	0.000961	0.00267	CcSEcCtD
Morphine—Anorexia—Furosemide—dilated cardiomyopathy	0.000956	0.00266	CcSEcCtD
Morphine—Mediastinal disorder—Lisinopril—dilated cardiomyopathy	0.000955	0.00265	CcSEcCtD
Morphine—Chills—Lisinopril—dilated cardiomyopathy	0.000951	0.00264	CcSEcCtD
Morphine—Hypotension—Furosemide—dilated cardiomyopathy	0.000937	0.0026	CcSEcCtD
Morphine—Mental disorder—Lisinopril—dilated cardiomyopathy	0.000928	0.00258	CcSEcCtD
Morphine—Malnutrition—Lisinopril—dilated cardiomyopathy	0.000922	0.00256	CcSEcCtD
Morphine—Erythema—Lisinopril—dilated cardiomyopathy	0.000922	0.00256	CcSEcCtD
Morphine—Flatulence—Lisinopril—dilated cardiomyopathy	0.000909	0.00252	CcSEcCtD
Morphine—Tension—Lisinopril—dilated cardiomyopathy	0.000905	0.00251	CcSEcCtD
Morphine—Dysgeusia—Lisinopril—dilated cardiomyopathy	0.000903	0.00251	CcSEcCtD
Morphine—Paraesthesia—Furosemide—dilated cardiomyopathy	0.000901	0.0025	CcSEcCtD
Morphine—Nervousness—Lisinopril—dilated cardiomyopathy	0.000896	0.00249	CcSEcCtD
Morphine—Back pain—Lisinopril—dilated cardiomyopathy	0.000892	0.00248	CcSEcCtD
Morphine—Somnolence—Furosemide—dilated cardiomyopathy	0.000892	0.00248	CcSEcCtD
Morphine—Muscle spasms—Lisinopril—dilated cardiomyopathy	0.000887	0.00246	CcSEcCtD
Morphine—Decreased appetite—Furosemide—dilated cardiomyopathy	0.000872	0.00242	CcSEcCtD
Morphine—Vision blurred—Lisinopril—dilated cardiomyopathy	0.000869	0.00241	CcSEcCtD
Morphine—Gastrointestinal disorder—Furosemide—dilated cardiomyopathy	0.000866	0.00241	CcSEcCtD
Morphine—Fatigue—Furosemide—dilated cardiomyopathy	0.000865	0.0024	CcSEcCtD
Morphine—Tremor—Lisinopril—dilated cardiomyopathy	0.000864	0.0024	CcSEcCtD
Morphine—ABCB1—heart—dilated cardiomyopathy	0.000864	0.00933	CbGeAlD
Morphine—Pain—Furosemide—dilated cardiomyopathy	0.000858	0.00238	CcSEcCtD
Morphine—Constipation—Furosemide—dilated cardiomyopathy	0.000858	0.00238	CcSEcCtD
Morphine—Ill-defined disorder—Lisinopril—dilated cardiomyopathy	0.000856	0.00238	CcSEcCtD
Morphine—Anaemia—Lisinopril—dilated cardiomyopathy	0.000852	0.00237	CcSEcCtD
Morphine—Malaise—Lisinopril—dilated cardiomyopathy	0.000832	0.00231	CcSEcCtD
Morphine—Vertigo—Lisinopril—dilated cardiomyopathy	0.000829	0.0023	CcSEcCtD
Morphine—Syncope—Lisinopril—dilated cardiomyopathy	0.000827	0.0023	CcSEcCtD
Morphine—Feeling abnormal—Furosemide—dilated cardiomyopathy	0.000827	0.0023	CcSEcCtD
Morphine—Leukopenia—Lisinopril—dilated cardiomyopathy	0.000826	0.00229	CcSEcCtD
Morphine—Gastrointestinal pain—Furosemide—dilated cardiomyopathy	0.00082	0.00228	CcSEcCtD
Morphine—Palpitations—Lisinopril—dilated cardiomyopathy	0.000815	0.00226	CcSEcCtD
Morphine—Loss of consciousness—Lisinopril—dilated cardiomyopathy	0.000811	0.00225	CcSEcCtD
Morphine—Cough—Lisinopril—dilated cardiomyopathy	0.000805	0.00224	CcSEcCtD
Morphine—Urticaria—Furosemide—dilated cardiomyopathy	0.000797	0.00221	CcSEcCtD
Morphine—Abdominal pain—Furosemide—dilated cardiomyopathy	0.000793	0.0022	CcSEcCtD
Morphine—Body temperature increased—Furosemide—dilated cardiomyopathy	0.000793	0.0022	CcSEcCtD
Morphine—Arthralgia—Lisinopril—dilated cardiomyopathy	0.000785	0.00218	CcSEcCtD
Morphine—Chest pain—Lisinopril—dilated cardiomyopathy	0.000785	0.00218	CcSEcCtD
Morphine—Anxiety—Lisinopril—dilated cardiomyopathy	0.000783	0.00217	CcSEcCtD
Morphine—Unspecified disorder of skin and subcutaneous tissue—Lisinopril—dilated cardiomyopathy	0.00078	0.00217	CcSEcCtD
Morphine—Discomfort—Lisinopril—dilated cardiomyopathy	0.000776	0.00215	CcSEcCtD
Morphine—Dry mouth—Lisinopril—dilated cardiomyopathy	0.000768	0.00213	CcSEcCtD
Morphine—Confusional state—Lisinopril—dilated cardiomyopathy	0.000759	0.00211	CcSEcCtD
Morphine—Anaphylactic shock—Lisinopril—dilated cardiomyopathy	0.000753	0.00209	CcSEcCtD
Morphine—Oedema—Lisinopril—dilated cardiomyopathy	0.000753	0.00209	CcSEcCtD
Morphine—Infection—Lisinopril—dilated cardiomyopathy	0.000748	0.00208	CcSEcCtD
Morphine—Shock—Lisinopril—dilated cardiomyopathy	0.000741	0.00206	CcSEcCtD
Morphine—Hypersensitivity—Furosemide—dilated cardiomyopathy	0.000739	0.00205	CcSEcCtD
Morphine—Thrombocytopenia—Lisinopril—dilated cardiomyopathy	0.000737	0.00205	CcSEcCtD
Morphine—Tachycardia—Lisinopril—dilated cardiomyopathy	0.000735	0.00204	CcSEcCtD
Morphine—Skin disorder—Lisinopril—dilated cardiomyopathy	0.000731	0.00203	CcSEcCtD
Morphine—Hyperhidrosis—Lisinopril—dilated cardiomyopathy	0.000728	0.00202	CcSEcCtD
Morphine—Asthenia—Furosemide—dilated cardiomyopathy	0.00072	0.002	CcSEcCtD
Morphine—Anorexia—Lisinopril—dilated cardiomyopathy	0.000718	0.00199	CcSEcCtD
Morphine—Pruritus—Furosemide—dilated cardiomyopathy	0.00071	0.00197	CcSEcCtD
Morphine—Hypotension—Lisinopril—dilated cardiomyopathy	0.000703	0.00195	CcSEcCtD
Morphine—Diarrhoea—Furosemide—dilated cardiomyopathy	0.000686	0.00191	CcSEcCtD
Morphine—Musculoskeletal discomfort—Lisinopril—dilated cardiomyopathy	0.000686	0.0019	CcSEcCtD
Morphine—Insomnia—Lisinopril—dilated cardiomyopathy	0.000681	0.00189	CcSEcCtD
Morphine—Paraesthesia—Lisinopril—dilated cardiomyopathy	0.000676	0.00188	CcSEcCtD
Morphine—Dyspnoea—Lisinopril—dilated cardiomyopathy	0.000671	0.00186	CcSEcCtD
Morphine—Somnolence—Lisinopril—dilated cardiomyopathy	0.000669	0.00186	CcSEcCtD
Morphine—Dizziness—Furosemide—dilated cardiomyopathy	0.000663	0.00184	CcSEcCtD
Morphine—Dyspepsia—Lisinopril—dilated cardiomyopathy	0.000663	0.00184	CcSEcCtD
Morphine—Decreased appetite—Lisinopril—dilated cardiomyopathy	0.000654	0.00182	CcSEcCtD
Morphine—Gastrointestinal disorder—Lisinopril—dilated cardiomyopathy	0.00065	0.0018	CcSEcCtD
Morphine—Fatigue—Lisinopril—dilated cardiomyopathy	0.000649	0.0018	CcSEcCtD
Morphine—Constipation—Lisinopril—dilated cardiomyopathy	0.000644	0.00179	CcSEcCtD
Morphine—Pain—Lisinopril—dilated cardiomyopathy	0.000644	0.00179	CcSEcCtD
Morphine—Vomiting—Furosemide—dilated cardiomyopathy	0.000638	0.00177	CcSEcCtD
Morphine—Rash—Furosemide—dilated cardiomyopathy	0.000633	0.00176	CcSEcCtD
Morphine—Dermatitis—Furosemide—dilated cardiomyopathy	0.000632	0.00176	CcSEcCtD
Morphine—Headache—Furosemide—dilated cardiomyopathy	0.000628	0.00175	CcSEcCtD
Morphine—Feeling abnormal—Lisinopril—dilated cardiomyopathy	0.00062	0.00172	CcSEcCtD
Morphine—Gastrointestinal pain—Lisinopril—dilated cardiomyopathy	0.000616	0.00171	CcSEcCtD
Morphine—Urticaria—Lisinopril—dilated cardiomyopathy	0.000598	0.00166	CcSEcCtD
Morphine—Nausea—Furosemide—dilated cardiomyopathy	0.000596	0.00165	CcSEcCtD
Morphine—Abdominal pain—Lisinopril—dilated cardiomyopathy	0.000595	0.00165	CcSEcCtD
Morphine—Body temperature increased—Lisinopril—dilated cardiomyopathy	0.000595	0.00165	CcSEcCtD
Morphine—Hypersensitivity—Lisinopril—dilated cardiomyopathy	0.000555	0.00154	CcSEcCtD
Morphine—Asthenia—Lisinopril—dilated cardiomyopathy	0.00054	0.0015	CcSEcCtD
Morphine—Pruritus—Lisinopril—dilated cardiomyopathy	0.000533	0.00148	CcSEcCtD
Morphine—Diarrhoea—Lisinopril—dilated cardiomyopathy	0.000515	0.00143	CcSEcCtD
Morphine—Dizziness—Lisinopril—dilated cardiomyopathy	0.000498	0.00138	CcSEcCtD
Morphine—Vomiting—Lisinopril—dilated cardiomyopathy	0.000479	0.00133	CcSEcCtD
Morphine—Rash—Lisinopril—dilated cardiomyopathy	0.000475	0.00132	CcSEcCtD
Morphine—Dermatitis—Lisinopril—dilated cardiomyopathy	0.000474	0.00132	CcSEcCtD
Morphine—Headache—Lisinopril—dilated cardiomyopathy	0.000472	0.00131	CcSEcCtD
Morphine—Nausea—Lisinopril—dilated cardiomyopathy	0.000447	0.00124	CcSEcCtD
Morphine—OPRD1—Class A/1 (Rhodopsin-like receptors)—CXCR3—dilated cardiomyopathy	0.000268	0.00323	CbGpPWpGaD
Morphine—OPRK1—GPCRs, Class A Rhodopsin-like—ADRB1—dilated cardiomyopathy	0.000266	0.0032	CbGpPWpGaD
Morphine—OPRL1—Signaling by GPCR—CXCL2—dilated cardiomyopathy	0.000264	0.00318	CbGpPWpGaD
Morphine—OPRL1—Signaling by GPCR—AGTR2—dilated cardiomyopathy	0.000264	0.00318	CbGpPWpGaD
Morphine—OPRL1—GPCR downstream signaling—ADRB1—dilated cardiomyopathy	0.000262	0.00315	CbGpPWpGaD
Morphine—UGT1A1—Aryl Hydrocarbon Receptor Pathway—EGFR—dilated cardiomyopathy	0.000261	0.00314	CbGpPWpGaD
Morphine—OPRD1—Class A/1 (Rhodopsin-like receptors)—ADRB1—dilated cardiomyopathy	0.00026	0.00312	CbGpPWpGaD
Morphine—OPRD1—GPCRs, Class A Rhodopsin-like—AGTR1—dilated cardiomyopathy	0.000259	0.00311	CbGpPWpGaD
Morphine—OPRK1—Class A/1 (Rhodopsin-like receptors)—CXCL2—dilated cardiomyopathy	0.000253	0.00304	CbGpPWpGaD
Morphine—OPRK1—Class A/1 (Rhodopsin-like receptors)—AGTR2—dilated cardiomyopathy	0.000253	0.00304	CbGpPWpGaD
Morphine—OPRM1—G alpha (i) signalling events—CXCR3—dilated cardiomyopathy	0.00025	0.00301	CbGpPWpGaD
Morphine—OPRM1—GPCRs, Class A Rhodopsin-like—AGTR2—dilated cardiomyopathy	0.000249	0.003	CbGpPWpGaD
Morphine—UGT1A1—Aryl Hydrocarbon Receptor Pathway—TNF—dilated cardiomyopathy	0.000249	0.00299	CbGpPWpGaD
Morphine—OPRD1—GPCRs, Class A Rhodopsin-like—ADRB2—dilated cardiomyopathy	0.000246	0.00295	CbGpPWpGaD
Morphine—OPRL1—Signaling by GPCR—CXCR3—dilated cardiomyopathy	0.000245	0.00295	CbGpPWpGaD
Morphine—OPRM1—Peptide ligand-binding receptors—AGTR1—dilated cardiomyopathy	0.000245	0.00295	CbGpPWpGaD
Morphine—OPRL1—Signaling by GPCR—ADRB1—dilated cardiomyopathy	0.000238	0.00286	CbGpPWpGaD
Morphine—OPRK1—Class A/1 (Rhodopsin-like receptors)—CXCR3—dilated cardiomyopathy	0.000235	0.00283	CbGpPWpGaD
Morphine—UGT1A3—Metabolism—ANKRD1—dilated cardiomyopathy	0.000233	0.00281	CbGpPWpGaD
Morphine—OPRD1—Peptide ligand-binding receptors—AGT—dilated cardiomyopathy	0.000233	0.0028	CbGpPWpGaD
Morphine—ABCB1—Allograft Rejection—AGTR1—dilated cardiomyopathy	0.000232	0.00279	CbGpPWpGaD
Morphine—OPRM1—GPCRs, Class A Rhodopsin-like—CXCR3—dilated cardiomyopathy	0.000232	0.00279	CbGpPWpGaD
Morphine—OPRK1—Class A/1 (Rhodopsin-like receptors)—ADRB1—dilated cardiomyopathy	0.000228	0.00274	CbGpPWpGaD
Morphine—OPRK1—GPCRs, Class A Rhodopsin-like—AGTR1—dilated cardiomyopathy	0.000227	0.00273	CbGpPWpGaD
Morphine—OPRM1—GPCRs, Class A Rhodopsin-like—ADRB1—dilated cardiomyopathy	0.000225	0.0027	CbGpPWpGaD
Morphine—OPRL1—GPCR downstream signaling—AGTR1—dilated cardiomyopathy	0.000224	0.00269	CbGpPWpGaD
Morphine—OPRD1—Class A/1 (Rhodopsin-like receptors)—AGTR1—dilated cardiomyopathy	0.000222	0.00267	CbGpPWpGaD
Morphine—OPRD1—GPCR ligand binding—AGTR2—dilated cardiomyopathy	0.00022	0.00264	CbGpPWpGaD
Morphine—OPRD1—GPCR ligand binding—CXCL2—dilated cardiomyopathy	0.00022	0.00264	CbGpPWpGaD
Morphine—UGT1A3—Metabolism—TAZ—dilated cardiomyopathy	0.000219	0.00264	CbGpPWpGaD
Morphine—OPRM1—TCR Signaling Pathway—RAF1—dilated cardiomyopathy	0.000218	0.00262	CbGpPWpGaD
Morphine—OPRK1—GPCRs, Class A Rhodopsin-like—ADRB2—dilated cardiomyopathy	0.000215	0.00259	CbGpPWpGaD
Morphine—OPRM1—Class A/1 (Rhodopsin-like receptors)—CXCL2—dilated cardiomyopathy	0.000214	0.00257	CbGpPWpGaD
Morphine—OPRM1—Class A/1 (Rhodopsin-like receptors)—AGTR2—dilated cardiomyopathy	0.000214	0.00257	CbGpPWpGaD
Morphine—OPRL1—GPCR downstream signaling—ADRB2—dilated cardiomyopathy	0.000212	0.00255	CbGpPWpGaD
Morphine—OPRD1—Class A/1 (Rhodopsin-like receptors)—ADRB2—dilated cardiomyopathy	0.00021	0.00253	CbGpPWpGaD
Morphine—OPRD1—GPCR ligand binding—CXCR3—dilated cardiomyopathy	0.000204	0.00246	CbGpPWpGaD
Morphine—OPRK1—Peptide ligand-binding receptors—AGT—dilated cardiomyopathy	0.000204	0.00245	CbGpPWpGaD
Morphine—OPRL1—Signaling by GPCR—AGTR1—dilated cardiomyopathy	0.000203	0.00244	CbGpPWpGaD
Morphine—OPRM1—Class A/1 (Rhodopsin-like receptors)—CXCR3—dilated cardiomyopathy	0.000199	0.00239	CbGpPWpGaD
Morphine—UGT1A3—Metabolism—SDHA—dilated cardiomyopathy	0.000198	0.00239	CbGpPWpGaD
Morphine—UGT2B7—Metabolism—ANKRD1—dilated cardiomyopathy	0.000198	0.00239	CbGpPWpGaD
Morphine—OPRD1—GPCR ligand binding—ADRB1—dilated cardiomyopathy	0.000198	0.00238	CbGpPWpGaD
Morphine—OPRD1—G alpha (i) signalling events—AGT—dilated cardiomyopathy	0.000196	0.00236	CbGpPWpGaD
Morphine—OPRK1—Class A/1 (Rhodopsin-like receptors)—AGTR1—dilated cardiomyopathy	0.000194	0.00234	CbGpPWpGaD
Morphine—ABCB1—Allograft Rejection—IL10—dilated cardiomyopathy	0.000194	0.00234	CbGpPWpGaD
Morphine—OPRL1—Signaling by GPCR—ADRB2—dilated cardiomyopathy	0.000193	0.00232	CbGpPWpGaD
Morphine—OPRK1—GPCR ligand binding—CXCL2—dilated cardiomyopathy	0.000193	0.00232	CbGpPWpGaD
Morphine—OPRK1—GPCR ligand binding—AGTR2—dilated cardiomyopathy	0.000193	0.00232	CbGpPWpGaD
Morphine—OPRM1—Class A/1 (Rhodopsin-like receptors)—ADRB1—dilated cardiomyopathy	0.000192	0.00231	CbGpPWpGaD
Morphine—OPRM1—GPCRs, Class A Rhodopsin-like—AGTR1—dilated cardiomyopathy	0.000192	0.00231	CbGpPWpGaD
Morphine—CYP2C8—Metabolism of lipids and lipoproteins—ANKRD1—dilated cardiomyopathy	0.000191	0.00229	CbGpPWpGaD
Morphine—UGT2B7—Metabolism—TAZ—dilated cardiomyopathy	0.000186	0.00224	CbGpPWpGaD
Morphine—OPRK1—Class A/1 (Rhodopsin-like receptors)—ADRB2—dilated cardiomyopathy	0.000184	0.00222	CbGpPWpGaD
Morphine—OPRM1—GPCRs, Class A Rhodopsin-like—ADRB2—dilated cardiomyopathy	0.000182	0.00219	CbGpPWpGaD
Morphine—ABCB1—Allograft Rejection—FASLG—dilated cardiomyopathy	0.000181	0.00217	CbGpPWpGaD
Morphine—CYP2C8—Metabolism of lipids and lipoproteins—TAZ—dilated cardiomyopathy	0.000179	0.00216	CbGpPWpGaD
Morphine—OPRK1—GPCR ligand binding—CXCR3—dilated cardiomyopathy	0.000179	0.00215	CbGpPWpGaD
Morphine—OPRL1—Signaling Pathways—PSEN2—dilated cardiomyopathy	0.000176	0.00211	CbGpPWpGaD
Morphine—ABCB1—Allograft Rejection—FAS—dilated cardiomyopathy	0.000174	0.0021	CbGpPWpGaD
Morphine—OPRK1—GPCR ligand binding—ADRB1—dilated cardiomyopathy	0.000173	0.00209	CbGpPWpGaD
Morphine—OPRM1—Peptide ligand-binding receptors—AGT—dilated cardiomyopathy	0.000172	0.00207	CbGpPWpGaD
Morphine—OPRK1—G alpha (i) signalling events—AGT—dilated cardiomyopathy	0.000172	0.00207	CbGpPWpGaD
Morphine—OPRD1—GPCR ligand binding—AGTR1—dilated cardiomyopathy	0.000169	0.00203	CbGpPWpGaD
Morphine—UGT2B7—Metabolism—SDHA—dilated cardiomyopathy	0.000169	0.00203	CbGpPWpGaD
Morphine—OPRL1—GPCR downstream signaling—RAC1—dilated cardiomyopathy	0.000165	0.00198	CbGpPWpGaD
Morphine—OPRM1—Class A/1 (Rhodopsin-like receptors)—AGTR1—dilated cardiomyopathy	0.000164	0.00198	CbGpPWpGaD
Morphine—OPRM1—GPCR ligand binding—CXCL2—dilated cardiomyopathy	0.000163	0.00196	CbGpPWpGaD
Morphine—OPRM1—GPCR ligand binding—AGTR2—dilated cardiomyopathy	0.000163	0.00196	CbGpPWpGaD
Morphine—UGT1A1—Metabolism—ANKRD1—dilated cardiomyopathy	0.000161	0.00194	CbGpPWpGaD
Morphine—OPRD1—GPCR ligand binding—ADRB2—dilated cardiomyopathy	0.00016	0.00193	CbGpPWpGaD
Morphine—OPRL1—GPCR downstream signaling—AGT—dilated cardiomyopathy	0.000157	0.00189	CbGpPWpGaD
Morphine—OPRD1—Class A/1 (Rhodopsin-like receptors)—AGT—dilated cardiomyopathy	0.000156	0.00188	CbGpPWpGaD
Morphine—OPRL1—Signaling Pathways—CXCL2—dilated cardiomyopathy	0.000156	0.00188	CbGpPWpGaD
Morphine—OPRL1—Signaling Pathways—AGTR2—dilated cardiomyopathy	0.000156	0.00188	CbGpPWpGaD
Morphine—OPRM1—Class A/1 (Rhodopsin-like receptors)—ADRB2—dilated cardiomyopathy	0.000156	0.00188	CbGpPWpGaD
Morphine—UGT1A1—Metabolism—TAZ—dilated cardiomyopathy	0.000152	0.00182	CbGpPWpGaD
Morphine—OPRM1—GPCR ligand binding—CXCR3—dilated cardiomyopathy	0.000151	0.00182	CbGpPWpGaD
Morphine—OPRL1—Signaling by GPCR—RAC1—dilated cardiomyopathy	0.00015	0.0018	CbGpPWpGaD
Morphine—OPRK1—GPCR ligand binding—AGTR1—dilated cardiomyopathy	0.000148	0.00178	CbGpPWpGaD
Morphine—OPRM1—GPCR ligand binding—ADRB1—dilated cardiomyopathy	0.000147	0.00176	CbGpPWpGaD
Morphine—OPRM1—G alpha (i) signalling events—AGT—dilated cardiomyopathy	0.000145	0.00175	CbGpPWpGaD
Morphine—OPRL1—Signaling Pathways—CXCR3—dilated cardiomyopathy	0.000145	0.00174	CbGpPWpGaD
Morphine—OPRL1—Signaling by GPCR—AGT—dilated cardiomyopathy	0.000143	0.00172	CbGpPWpGaD
Morphine—OPRK1—GPCR ligand binding—ADRB2—dilated cardiomyopathy	0.00014	0.00169	CbGpPWpGaD
Morphine—OPRL1—Signaling Pathways—ADRB1—dilated cardiomyopathy	0.00014	0.00169	CbGpPWpGaD
Morphine—UGT1A1—Metabolism—SDHA—dilated cardiomyopathy	0.000137	0.00165	CbGpPWpGaD
Morphine—OPRK1—Class A/1 (Rhodopsin-like receptors)—AGT—dilated cardiomyopathy	0.000137	0.00165	CbGpPWpGaD
Morphine—OPRM1—GPCR ligand binding—AGTR1—dilated cardiomyopathy	0.000125	0.00151	CbGpPWpGaD
Morphine—OPRD1—GPCR downstream signaling—CXCL2—dilated cardiomyopathy	0.000124	0.00149	CbGpPWpGaD
Morphine—OPRD1—GPCR downstream signaling—AGTR2—dilated cardiomyopathy	0.000124	0.00149	CbGpPWpGaD
Morphine—OPRL1—Signaling Pathways—AGTR1—dilated cardiomyopathy	0.00012	0.00144	CbGpPWpGaD
Morphine—OPRD1—GPCR ligand binding—AGT—dilated cardiomyopathy	0.000119	0.00143	CbGpPWpGaD
Morphine—OPRM1—GPCR ligand binding—ADRB2—dilated cardiomyopathy	0.000119	0.00143	CbGpPWpGaD
Morphine—OPRM1—Class A/1 (Rhodopsin-like receptors)—AGT—dilated cardiomyopathy	0.000116	0.00139	CbGpPWpGaD
Morphine—OPRD1—GPCR downstream signaling—CXCR3—dilated cardiomyopathy	0.000115	0.00139	CbGpPWpGaD
Morphine—UGT1A8—Metabolism—GPX1—dilated cardiomyopathy	0.000115	0.00138	CbGpPWpGaD
Morphine—OPRL1—Signaling Pathways—ADRB2—dilated cardiomyopathy	0.000114	0.00137	CbGpPWpGaD
Morphine—OPRD1—Signaling by GPCR—AGTR2—dilated cardiomyopathy	0.000113	0.00136	CbGpPWpGaD
Morphine—OPRD1—Signaling by GPCR—CXCL2—dilated cardiomyopathy	0.000113	0.00136	CbGpPWpGaD
Morphine—ABCB1—Transmembrane transport of small molecules—RYR2—dilated cardiomyopathy	0.000112	0.00135	CbGpPWpGaD
Morphine—UGT1A8—Metabolism—CD36—dilated cardiomyopathy	0.000112	0.00135	CbGpPWpGaD
Morphine—OPRD1—GPCR downstream signaling—ADRB1—dilated cardiomyopathy	0.000112	0.00134	CbGpPWpGaD
Morphine—ABCB1—Transmembrane transport of small molecules—SLC22A5—dilated cardiomyopathy	0.000109	0.00132	CbGpPWpGaD
Morphine—ABCB1—Transmembrane transport of small molecules—PLN—dilated cardiomyopathy	0.000109	0.00132	CbGpPWpGaD
Morphine—OPRK1—GPCR downstream signaling—CXCL2—dilated cardiomyopathy	0.000109	0.00131	CbGpPWpGaD
Morphine—OPRK1—GPCR downstream signaling—AGTR2—dilated cardiomyopathy	0.000109	0.00131	CbGpPWpGaD
Morphine—OPRD1—Signaling by GPCR—CXCR3—dilated cardiomyopathy	0.000105	0.00126	CbGpPWpGaD
Morphine—OPRK1—GPCR ligand binding—AGT—dilated cardiomyopathy	0.000104	0.00125	CbGpPWpGaD
Morphine—ABCB1—Transmembrane transport of small molecules—ABCC9—dilated cardiomyopathy	0.000102	0.00122	CbGpPWpGaD
Morphine—OPRD1—Signaling by GPCR—ADRB1—dilated cardiomyopathy	0.000101	0.00122	CbGpPWpGaD
Morphine—OPRK1—GPCR downstream signaling—CXCR3—dilated cardiomyopathy	0.000101	0.00122	CbGpPWpGaD
Morphine—UGT1A8—Metabolism—AGT—dilated cardiomyopathy	0.000101	0.00121	CbGpPWpGaD
Morphine—UGT2B15—Metabolism—GPX1—dilated cardiomyopathy	0.000101	0.00121	CbGpPWpGaD
Morphine—UGT2B4—Metabolism—GPX1—dilated cardiomyopathy	0.000101	0.00121	CbGpPWpGaD
Morphine—OPRL1—Signaling by GPCR—RAF1—dilated cardiomyopathy	9.91e-05	0.00119	CbGpPWpGaD
Morphine—OPRK1—Signaling by GPCR—AGTR2—dilated cardiomyopathy	9.88e-05	0.00119	CbGpPWpGaD
Morphine—OPRK1—Signaling by GPCR—CXCL2—dilated cardiomyopathy	9.88e-05	0.00119	CbGpPWpGaD
Morphine—OPRK1—GPCR downstream signaling—ADRB1—dilated cardiomyopathy	9.8e-05	0.00118	CbGpPWpGaD
Morphine—UGT2B4—Metabolism—CD36—dilated cardiomyopathy	9.8e-05	0.00118	CbGpPWpGaD
Morphine—UGT2B15—Metabolism—CD36—dilated cardiomyopathy	9.8e-05	0.00118	CbGpPWpGaD
Morphine—OPRL1—Signaling Pathways—RPS6KB1—dilated cardiomyopathy	9.78e-05	0.00118	CbGpPWpGaD
Morphine—OPRD1—GPCR downstream signaling—AGTR1—dilated cardiomyopathy	9.54e-05	0.00115	CbGpPWpGaD
Morphine—OPRM1—GPCR downstream signaling—CXCL2—dilated cardiomyopathy	9.2e-05	0.00111	CbGpPWpGaD
Morphine—OPRM1—GPCR downstream signaling—AGTR2—dilated cardiomyopathy	9.2e-05	0.00111	CbGpPWpGaD
Morphine—OPRK1—Signaling by GPCR—CXCR3—dilated cardiomyopathy	9.19e-05	0.00111	CbGpPWpGaD
Morphine—OPRD1—GPCR downstream signaling—ADRB2—dilated cardiomyopathy	9.05e-05	0.00109	CbGpPWpGaD
Morphine—ABCB1—Integrated Pancreatic Cancer Pathway—FASLG—dilated cardiomyopathy	8.92e-05	0.00107	CbGpPWpGaD
Morphine—OPRK1—Signaling by GPCR—ADRB1—dilated cardiomyopathy	8.9e-05	0.00107	CbGpPWpGaD
Morphine—OPRL1—Signaling Pathways—RAC1—dilated cardiomyopathy	8.83e-05	0.00106	CbGpPWpGaD
Morphine—UGT2B4—Metabolism—AGT—dilated cardiomyopathy	8.82e-05	0.00106	CbGpPWpGaD
Morphine—UGT2B15—Metabolism—AGT—dilated cardiomyopathy	8.82e-05	0.00106	CbGpPWpGaD
Morphine—OPRM1—GPCR ligand binding—AGT—dilated cardiomyopathy	8.81e-05	0.00106	CbGpPWpGaD
Morphine—OPRD1—Signaling by GPCR—AGTR1—dilated cardiomyopathy	8.66e-05	0.00104	CbGpPWpGaD
Morphine—ABCB1—Integrated Pancreatic Cancer Pathway—FAS—dilated cardiomyopathy	8.6e-05	0.00103	CbGpPWpGaD
Morphine—OPRM1—GPCR downstream signaling—CXCR3—dilated cardiomyopathy	8.55e-05	0.00103	CbGpPWpGaD
Morphine—CYP2C8—Metabolism—ANKRD1—dilated cardiomyopathy	8.49e-05	0.00102	CbGpPWpGaD
Morphine—OPRL1—Signaling Pathways—AGT—dilated cardiomyopathy	8.44e-05	0.00102	CbGpPWpGaD
Morphine—ABCB1—Integrated Pancreatic Cancer Pathway—RAC1—dilated cardiomyopathy	8.43e-05	0.00101	CbGpPWpGaD
Morphine—OPRK1—GPCR downstream signaling—AGTR1—dilated cardiomyopathy	8.37e-05	0.00101	CbGpPWpGaD
Morphine—OPRM1—Signaling by GPCR—CXCL2—dilated cardiomyopathy	8.35e-05	0.001	CbGpPWpGaD
Morphine—OPRM1—Signaling by GPCR—AGTR2—dilated cardiomyopathy	8.35e-05	0.001	CbGpPWpGaD
Morphine—OPRM1—GPCR downstream signaling—ADRB1—dilated cardiomyopathy	8.28e-05	0.000996	CbGpPWpGaD
Morphine—OPRD1—Signaling by GPCR—ADRB2—dilated cardiomyopathy	8.22e-05	0.000989	CbGpPWpGaD
Morphine—CYP2C8—Metabolism—TAZ—dilated cardiomyopathy	7.98e-05	0.00096	CbGpPWpGaD
Morphine—OPRK1—GPCR downstream signaling—ADRB2—dilated cardiomyopathy	7.94e-05	0.000955	CbGpPWpGaD
Morphine—OPRM1—Signaling by GPCR—CXCR3—dilated cardiomyopathy	7.76e-05	0.000934	CbGpPWpGaD
Morphine—OPRK1—Signaling by GPCR—AGTR1—dilated cardiomyopathy	7.6e-05	0.000914	CbGpPWpGaD
Morphine—OPRM1—Signaling by GPCR—ADRB1—dilated cardiomyopathy	7.52e-05	0.000905	CbGpPWpGaD
Morphine—OPRD1—Signaling Pathways—PSEN2—dilated cardiomyopathy	7.5e-05	0.000902	CbGpPWpGaD
Morphine—ABCB1—Allograft Rejection—TNF—dilated cardiomyopathy	7.4e-05	0.00089	CbGpPWpGaD
Morphine—ABCB1—Metabolism—ANKRD1—dilated cardiomyopathy	7.39e-05	0.00089	CbGpPWpGaD
Morphine—CYP2C8—Metabolism—SDHA—dilated cardiomyopathy	7.22e-05	0.000868	CbGpPWpGaD
Morphine—OPRK1—Signaling by GPCR—ADRB2—dilated cardiomyopathy	7.21e-05	0.000867	CbGpPWpGaD
Morphine—OPRM1—GPCR downstream signaling—AGTR1—dilated cardiomyopathy	7.07e-05	0.000851	CbGpPWpGaD
Morphine—OPRD1—GPCR downstream signaling—RAC1—dilated cardiomyopathy	7.03e-05	0.000845	CbGpPWpGaD
Morphine—CYP2D6—Metabolism—ANKRD1—dilated cardiomyopathy	6.97e-05	0.000838	CbGpPWpGaD
Morphine—ABCB1—Metabolism—TAZ—dilated cardiomyopathy	6.95e-05	0.000836	CbGpPWpGaD
Morphine—OPRL1—Signaling by GPCR—EGFR—dilated cardiomyopathy	6.8e-05	0.000818	CbGpPWpGaD
Morphine—OPRD1—GPCR downstream signaling—AGT—dilated cardiomyopathy	6.71e-05	0.000808	CbGpPWpGaD
Morphine—OPRM1—GPCR downstream signaling—ADRB2—dilated cardiomyopathy	6.71e-05	0.000807	CbGpPWpGaD
Morphine—OPRD1—Signaling Pathways—CXCL2—dilated cardiomyopathy	6.66e-05	0.000801	CbGpPWpGaD
Morphine—OPRD1—Signaling Pathways—AGTR2—dilated cardiomyopathy	6.66e-05	0.000801	CbGpPWpGaD
Morphine—OPRK1—Signaling Pathways—PSEN2—dilated cardiomyopathy	6.57e-05	0.000791	CbGpPWpGaD
Morphine—CYP2D6—Metabolism—TAZ—dilated cardiomyopathy	6.55e-05	0.000788	CbGpPWpGaD
Morphine—OPRM1—Signaling by GPCR—AGTR1—dilated cardiomyopathy	6.42e-05	0.000773	CbGpPWpGaD
Morphine—OPRD1—Signaling by GPCR—RAC1—dilated cardiomyopathy	6.38e-05	0.000768	CbGpPWpGaD
Morphine—ABCB1—Metabolism—SDHA—dilated cardiomyopathy	6.29e-05	0.000756	CbGpPWpGaD
Morphine—OPRD1—Signaling Pathways—CXCR3—dilated cardiomyopathy	6.19e-05	0.000745	CbGpPWpGaD
Morphine—OPRK1—GPCR downstream signaling—RAC1—dilated cardiomyopathy	6.16e-05	0.000741	CbGpPWpGaD
Morphine—OPRD1—Signaling by GPCR—AGT—dilated cardiomyopathy	6.1e-05	0.000734	CbGpPWpGaD
Morphine—OPRM1—Signaling by GPCR—ADRB2—dilated cardiomyopathy	6.09e-05	0.000733	CbGpPWpGaD
Morphine—OPRD1—Signaling Pathways—ADRB1—dilated cardiomyopathy	5.99e-05	0.000721	CbGpPWpGaD
Morphine—CYP2D6—Metabolism—SDHA—dilated cardiomyopathy	5.92e-05	0.000713	CbGpPWpGaD
Morphine—OPRK1—GPCR downstream signaling—AGT—dilated cardiomyopathy	5.89e-05	0.000708	CbGpPWpGaD
Morphine—OPRL1—Signaling Pathways—RAF1—dilated cardiomyopathy	5.86e-05	0.000705	CbGpPWpGaD
Morphine—OPRK1—Signaling Pathways—CXCL2—dilated cardiomyopathy	5.84e-05	0.000702	CbGpPWpGaD
Morphine—OPRK1—Signaling Pathways—AGTR2—dilated cardiomyopathy	5.84e-05	0.000702	CbGpPWpGaD
Morphine—OPRK1—Signaling by GPCR—RAC1—dilated cardiomyopathy	5.6e-05	0.000673	CbGpPWpGaD
Morphine—ABCB1—Integrated Pancreatic Cancer Pathway—RAF1—dilated cardiomyopathy	5.59e-05	0.000672	CbGpPWpGaD
Morphine—OPRM1—Signaling Pathways—PSEN2—dilated cardiomyopathy	5.56e-05	0.000668	CbGpPWpGaD
Morphine—OPRK1—Signaling Pathways—CXCR3—dilated cardiomyopathy	5.43e-05	0.000653	CbGpPWpGaD
Morphine—UGT1A3—Metabolism—GPX1—dilated cardiomyopathy	5.39e-05	0.000648	CbGpPWpGaD
Morphine—OPRK1—Signaling by GPCR—AGT—dilated cardiomyopathy	5.35e-05	0.000643	CbGpPWpGaD
Morphine—OPRK1—Signaling Pathways—ADRB1—dilated cardiomyopathy	5.26e-05	0.000632	CbGpPWpGaD
Morphine—UGT1A3—Metabolism—CD36—dilated cardiomyopathy	5.25e-05	0.000631	CbGpPWpGaD
Morphine—OPRM1—GPCR downstream signaling—RAC1—dilated cardiomyopathy	5.21e-05	0.000627	CbGpPWpGaD
Morphine—OPRD1—Signaling Pathways—AGTR1—dilated cardiomyopathy	5.12e-05	0.000616	CbGpPWpGaD
Morphine—OPRM1—GPCR downstream signaling—AGT—dilated cardiomyopathy	4.98e-05	0.000599	CbGpPWpGaD
Morphine—OPRM1—Signaling Pathways—CXCL2—dilated cardiomyopathy	4.93e-05	0.000594	CbGpPWpGaD
Morphine—OPRM1—Signaling Pathways—AGTR2—dilated cardiomyopathy	4.93e-05	0.000594	CbGpPWpGaD
Morphine—OPRD1—Signaling Pathways—ADRB2—dilated cardiomyopathy	4.86e-05	0.000584	CbGpPWpGaD
Morphine—OPRM1—Signaling by GPCR—RAC1—dilated cardiomyopathy	4.73e-05	0.000569	CbGpPWpGaD
Morphine—UGT1A3—Metabolism—AGT—dilated cardiomyopathy	4.72e-05	0.000568	CbGpPWpGaD
Morphine—OPRM1—Signaling Pathways—CXCR3—dilated cardiomyopathy	4.59e-05	0.000552	CbGpPWpGaD
Morphine—UGT2B7—Metabolism—GPX1—dilated cardiomyopathy	4.58e-05	0.000551	CbGpPWpGaD
Morphine—CYP3A4—Metabolism—ANKRD1—dilated cardiomyopathy	4.56e-05	0.000548	CbGpPWpGaD
Morphine—OPRM1—Signaling by GPCR—AGT—dilated cardiomyopathy	4.52e-05	0.000544	CbGpPWpGaD
Morphine—OPRK1—Signaling Pathways—AGTR1—dilated cardiomyopathy	4.49e-05	0.00054	CbGpPWpGaD
Morphine—UGT2B7—Metabolism—CD36—dilated cardiomyopathy	4.46e-05	0.000537	CbGpPWpGaD
Morphine—OPRM1—Signaling Pathways—ADRB1—dilated cardiomyopathy	4.44e-05	0.000534	CbGpPWpGaD
Morphine—CYP2C8—Metabolism of lipids and lipoproteins—GPX1—dilated cardiomyopathy	4.4e-05	0.00053	CbGpPWpGaD
Morphine—CYP2C8—Metabolism of lipids and lipoproteins—CD36—dilated cardiomyopathy	4.29e-05	0.000516	CbGpPWpGaD
Morphine—CYP3A4—Metabolism—TAZ—dilated cardiomyopathy	4.28e-05	0.000515	CbGpPWpGaD
Morphine—OPRK1—Signaling Pathways—ADRB2—dilated cardiomyopathy	4.26e-05	0.000512	CbGpPWpGaD
Morphine—OPRD1—Signaling by GPCR—RAF1—dilated cardiomyopathy	4.23e-05	0.000509	CbGpPWpGaD
Morphine—OPRD1—Signaling Pathways—RPS6KB1—dilated cardiomyopathy	4.17e-05	0.000502	CbGpPWpGaD
Morphine—UGT2B7—Metabolism—AGT—dilated cardiomyopathy	4.02e-05	0.000483	CbGpPWpGaD
Morphine—OPRL1—Signaling Pathways—EGFR—dilated cardiomyopathy	4.02e-05	0.000483	CbGpPWpGaD
Morphine—CYP3A4—Metabolism—SDHA—dilated cardiomyopathy	3.87e-05	0.000466	CbGpPWpGaD
Morphine—CYP2C8—Metabolism of lipids and lipoproteins—AGT—dilated cardiomyopathy	3.86e-05	0.000464	CbGpPWpGaD
Morphine—ABCB1—Integrated Pancreatic Cancer Pathway—EGFR—dilated cardiomyopathy	3.83e-05	0.000461	CbGpPWpGaD
Morphine—OPRM1—Signaling Pathways—AGTR1—dilated cardiomyopathy	3.79e-05	0.000456	CbGpPWpGaD
Morphine—OPRD1—Signaling Pathways—RAC1—dilated cardiomyopathy	3.77e-05	0.000454	CbGpPWpGaD
Morphine—UGT1A1—Metabolism—GPX1—dilated cardiomyopathy	3.72e-05	0.000448	CbGpPWpGaD
Morphine—OPRK1—Signaling by GPCR—RAF1—dilated cardiomyopathy	3.71e-05	0.000446	CbGpPWpGaD
Morphine—OPRK1—Signaling Pathways—RPS6KB1—dilated cardiomyopathy	3.66e-05	0.00044	CbGpPWpGaD
Morphine—ABCB1—Integrated Pancreatic Cancer Pathway—TNF—dilated cardiomyopathy	3.65e-05	0.000439	CbGpPWpGaD
Morphine—UGT1A1—Metabolism—CD36—dilated cardiomyopathy	3.63e-05	0.000436	CbGpPWpGaD
Morphine—OPRD1—Signaling Pathways—AGT—dilated cardiomyopathy	3.6e-05	0.000433	CbGpPWpGaD
Morphine—OPRM1—Signaling Pathways—ADRB2—dilated cardiomyopathy	3.6e-05	0.000433	CbGpPWpGaD
Morphine—OPRK1—Signaling Pathways—RAC1—dilated cardiomyopathy	3.31e-05	0.000398	CbGpPWpGaD
Morphine—UGT1A1—Metabolism—AGT—dilated cardiomyopathy	3.26e-05	0.000393	CbGpPWpGaD
Morphine—OPRK1—Signaling Pathways—AGT—dilated cardiomyopathy	3.16e-05	0.00038	CbGpPWpGaD
Morphine—OPRM1—Signaling by GPCR—RAF1—dilated cardiomyopathy	3.14e-05	0.000377	CbGpPWpGaD
Morphine—OPRM1—Signaling Pathways—RPS6KB1—dilated cardiomyopathy	3.09e-05	0.000372	CbGpPWpGaD
Morphine—OPRD1—Signaling by GPCR—EGFR—dilated cardiomyopathy	2.9e-05	0.000349	CbGpPWpGaD
Morphine—OPRM1—Signaling Pathways—RAC1—dilated cardiomyopathy	2.79e-05	0.000336	CbGpPWpGaD
Morphine—OPRM1—Signaling Pathways—AGT—dilated cardiomyopathy	2.67e-05	0.000321	CbGpPWpGaD
Morphine—OPRK1—Signaling by GPCR—EGFR—dilated cardiomyopathy	2.54e-05	0.000306	CbGpPWpGaD
Morphine—OPRD1—Signaling Pathways—RAF1—dilated cardiomyopathy	2.5e-05	0.000301	CbGpPWpGaD
Morphine—ABCB1—Transmembrane transport of small molecules—RAF1—dilated cardiomyopathy	2.22e-05	0.000267	CbGpPWpGaD
Morphine—OPRK1—Signaling Pathways—RAF1—dilated cardiomyopathy	2.19e-05	0.000264	CbGpPWpGaD
Morphine—OPRM1—Signaling by GPCR—EGFR—dilated cardiomyopathy	2.15e-05	0.000259	CbGpPWpGaD
Morphine—CYP2C8—Metabolism—GPX1—dilated cardiomyopathy	1.96e-05	0.000236	CbGpPWpGaD
Morphine—CYP2C8—Metabolism—CD36—dilated cardiomyopathy	1.91e-05	0.00023	CbGpPWpGaD
Morphine—OPRM1—Signaling Pathways—RAF1—dilated cardiomyopathy	1.85e-05	0.000223	CbGpPWpGaD
Morphine—CYP2C8—Metabolism—AGT—dilated cardiomyopathy	1.72e-05	0.000207	CbGpPWpGaD
Morphine—OPRD1—Signaling Pathways—EGFR—dilated cardiomyopathy	1.71e-05	0.000206	CbGpPWpGaD
Morphine—ABCB1—Metabolism—GPX1—dilated cardiomyopathy	1.71e-05	0.000205	CbGpPWpGaD
Morphine—ABCB1—Metabolism—CD36—dilated cardiomyopathy	1.66e-05	0.0002	CbGpPWpGaD
Morphine—CYP2D6—Metabolism—GPX1—dilated cardiomyopathy	1.61e-05	0.000194	CbGpPWpGaD
Morphine—CYP2D6—Metabolism—CD36—dilated cardiomyopathy	1.57e-05	0.000189	CbGpPWpGaD
Morphine—OPRK1—Signaling Pathways—EGFR—dilated cardiomyopathy	1.5e-05	0.000181	CbGpPWpGaD
Morphine—ABCB1—Metabolism—AGT—dilated cardiomyopathy	1.5e-05	0.00018	CbGpPWpGaD
Morphine—CYP2D6—Metabolism—AGT—dilated cardiomyopathy	1.41e-05	0.00017	CbGpPWpGaD
Morphine—OPRM1—Signaling Pathways—EGFR—dilated cardiomyopathy	1.27e-05	0.000153	CbGpPWpGaD
Morphine—CYP3A4—Metabolism—GPX1—dilated cardiomyopathy	1.05e-05	0.000127	CbGpPWpGaD
Morphine—CYP3A4—Metabolism—CD36—dilated cardiomyopathy	1.02e-05	0.000123	CbGpPWpGaD
Morphine—CYP3A4—Metabolism—AGT—dilated cardiomyopathy	9.23e-06	0.000111	CbGpPWpGaD
